Masakazu Aihara
Overview
Explore the profile of Masakazu Aihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadowaki Y, Aoyama T, Hada Y, Aihara M, Sawada M, Sekine R, et al.
Endocr J
. 2024 Nov;
72(3):307-317.
PMID: 39603654
The Japan Society for the Study of Obesity recommends a weight loss of 3% of body weight over a period of 3-6 months. However, the effects of rapid weight loss...
2.
Aihara M, Yano K, Irie T, Nishi M, Yachiku K, Minoura I, et al.
Diabetes Res Clin Pract
. 2024 Oct;
218:111903.
PMID: 39447680
Aims: Measurements of diabetes-related biomarkers are necessary to assess glycemic control. The commonly used finger-prick blood glucose and HbA1c measurements are invasive, as is blood glycated albumin (GA) measurement. Therefore,...
3.
Hamano S, Sawada M, Aihara M, Sakurai Y, Sekine R, Usami S, et al.
Diabetes Obes Metab
. 2024 Sep;
26(11):5431-5443.
PMID: 39267249
Aim: To elucidate the effects of ultra-processed foods (UPFs) on body weight and ad libitum energy intake compared with non-UPFs. Materials And Methods: In this randomized, open-label crossover study conducted...
4.
Jinnouchi H, Yoshida A, Taniguchi M, Yamauchi E, Kurosawa D, Yachiku K, et al.
Diabetes Ther
. 2024 May;
15(7):1561-1575.
PMID: 38753121
Introduction: Lifestyle management, including appropriate modifications of nutrition, exercise, and medication behaviors, is essential for optimal glycemic control. The absence of appropriate monitoring methods to validate the lifestyle change may...
5.
Sakurai Y, Kubota N, Takamoto I, Wada N, Aihara M, Hayashi T, et al.
Diabetes
. 2023 Dec;
73(3):474-489.
PMID: 38064504
Genome-wide association studies have identified several gene polymorphisms, including UBE2E2, associated with type 2 diabetes. Although UBE2E2 is one of the ubiquitin-conjugating enzymes involved in the process of ubiquitin modifications,...
6.
Aihara M, Hayashi T, Koizumi C, Sakurai Y, Sawada M, Kubota T, et al.
Diabetes Ther
. 2023 Aug;
14(10):1711-1721.
PMID: 37568043
Introduction: Hemoglobin A1c (HbA1c), representing the average blood glucose over 1-2 months, is the most commonly used glycemic marker in people with diabetes. Glycated albumin (GA) reflects the average blood...
7.
Ohkuma K, Sawada M, Aihara M, Doi S, Sekine R, Usami S, et al.
J Diabetes Investig
. 2023 Apr;
14(8):985-993.
PMID: 37118898
Aim: To investigate the impact of the COVID-19 pandemic and its preventive measures on the glycemic and lipid control in people with diabetes mellitus (DM). Materials And Methods: We conducted...
8.
Aihara M, Jinnouchi H, Yoshida A, Ijima H, Sakurai Y, Hayashi T, et al.
Diabetes Res Clin Pract
. 2023 Mar;
199:110637.
PMID: 36963507
Aims: Glycated albumin (GA) is a biomarker, whose level reflects glycemic control status over the previous 2 weeks. To develop a non-invasive method for evaluating glycemic control in people with...
9.
Hayashi T, Wada N, Kubota T, Koizumi C, Sakurai Y, Aihara M, et al.
J Diabetes Investig
. 2023 Mar;
14(6):801-810.
PMID: 36934440
Aims/introduction: Patients with type 2 diabetes mellitus are reported to be at a high risk for sarcopenia, and are known to have a poorer sleep quality. However, the association between...
10.
Aihara M, Irie T, Yasukawa K, Minoura I, Miyauchi N, Nishi M, et al.
Clin Chim Acta
. 2023 Mar;
542:117272.
PMID: 36858193
Background: Home blood glucose monitoring can be effective for the self-management of diabetic patients. Hemoglobin A1c (HbA1c) is a widely used marker that reflects the average blood glucose within 1-2 ...